Formosa Laboratories Executive and Leadership Team

Chih-Ping Yang, the Chief Executive Officer at Formosa Laboratories, directs the overarching corporate strategy and operational execution. This leadership role involves guiding the company's expansion in API and UV-filter production, ensuring adherence to rigorous GMP compliance standards approved by international bodies such as the US FDA and PMDA of Japan. Yang oversees the development and commercialization of key product lines, including Vitamin D derivatives and essential UV-filters like avobenzone and Octinoxate. The Chief Executive Officer's responsibilities extend to fostering innovation within the modern facilities near Taipei and maintaining Formosa Laboratories' position as a major global producer. By driving strategic initiatives, Chih-Ping Yang ensures the company's continued growth and its capacity to offer comprehensive custom synthesis services from process development through full commercial production, complete with full documentation support.

Chen-Yu Cheng, the President at Formosa Laboratories, spearheads the company's operational efficiency and market penetration strategies. This executive focuses on optimizing the production of a diverse range of APIs, including Balsalazide, Benzonatate, and Montelukast, alongside critical UV-filter products. The President ensures that Formosa Laboratories' modern facilities near Taipei maintain the highest levels of GMP compliance, a standard recognized by regulatory authorities in Taiwan, the US, Germany, and Japan. Chen-Yu Cheng's leadership drives the company's capacity to serve as a major producer worldwide, managing the intricate processes involved in manufacturing specialty chemicals. By overseeing day-to-day operations, the President facilitates the company's custom synthesis services, guiding projects from initial process development to full commercial production, ensuring all documentation requirements are met.

C.Y. Cheng, the President at Formosa Laboratories, directs the strategic expansion and global market engagement for the company's pharmaceutical ingredients and UV-filters. This leadership position involves cultivating key international relationships and ensuring Formosa Laboratories' products meet the stringent GMP compliance requirements set by global health authorities, including the US FDA and Japan's PMDA. C.Y. Cheng oversees the efficient production of a wide array of APIs, such as Vitamin D derivatives and Sevelamer, as well as vital UV-filters like avobenzone. The President's focus extends to enhancing the company's custom synthesis services, managing the transition from process development to large-scale commercial manufacturing with robust documentation support. C.Y. Cheng drives initiatives that solidify Formosa Laboratories' status as a significant global supplier.

C.P. Yang, the President at Formosa Laboratories, champions the company's commitment to innovation and quality in API and UV-filter manufacturing. This executive role involves overseeing the advanced production processes within the modern facilities near Taipei, ensuring consistent adherence to GMP compliance standards validated by Taiwan's DOH, US FDA, and Germany's BGV. C.P. Yang directs the strategic development and market introduction of Formosa Laboratories' extensive product portfolio, which includes specialized APIs like Capsaicin and Colesevelam, and essential UV-filters such as Octinoxate. The President's responsibilities encompass driving the company's custom synthesis services, managing the entire lifecycle from process development to full commercial production, including comprehensive documentation. C.P. Yang ensures Formosa Laboratories maintains its competitive edge as a major global producer.